Archon emerges from stealth with $20M and ‘antibody cages’ to power up drug development
Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an impressive $20 million in seed funding. The company aims to supercharge antibody treatments using specially designed protein...